Primary Carnitine Deficiency Treatments
Find Primary Carnitine Deficiency Treatments
Carnitor
What is Carnitor (Levocarnitine)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Summary: The goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions it aims to answer are: * Does supplementation improve the number and quality of oocytes retrieved during IVF treatment? ...
Summary: Phase II/III multicenter, randomized, double-blind, placebo-controlled trial on acetyl-L-carnitine (ALCAR) in subjects living with amyotrophic lateral sclerosis (ALS). Primary study aim: The clinical objective consists of assessing the efficacy of ALCAR (two different dosages will be tested: 1.5g/day and 3g/day) on the progression of functional disability (loss of self-sufficiency), as measured by...
Summary: This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.
Related Latest Advances
Brand Information

- Bohmer, T., Rydning, A. and Solberg, H.E. 1974. Carnitine levels in human serum in health and disease.
- Brooks, H., Goldberg, L., Holland, R.
- Christiansen, R., Bremer, J. 1976. Active transport of butyrobetaine and carnitine into isolated liver cells.
- Lindstedt, S. and Lindstedt, G. 1961. Distribution and excretion of carnitine in the rat.
- Rebouche, C.J. and Engel, A.G. 1983. Carnitine metabolism and deficiency syndromes.
- Rebouche, C.J. and Paulson, D.J. 1986. Carnitine metabolism and function in humans.
- Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. 1989.
- Schaub, J., Van Hoof, F. and Vis, H.L. 1991.
- Marzo, A., Arrigoni Martelli, E., Mancinelli, A., Cardace, G., Corbelletta, C., Bassani, E. and Solbiati, M. 1991. Protein binding of L-carnitine family components.
- Rebouche, C.J. 1991. Quantitative estimation of absorption and degradation of a carnitine supplement by human adults.

Date of Issue: 07/23 OPI-16
(levocarnitine) Oral Solution

